NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy

NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy

Boksoon Chang,1 Myung Jae Park,1 Sue In Choi,2 Kwang Ho In,2 Chul Hwan Kim,3 Seung Hyeun Lee1 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University School of Medicine, 2Division of Respiratory and Critical Care Medicine, Department of Internal Medi...

Full description

Bibliographic Details
Main Authors: Chang B, Park MJ, Choi SI, In KH, Kim CH, Lee SH
Format: Article
Language:English
Published: Dove Medical Press 2017-09-01
Series:OncoTargets and Therapy
Subjects:
lung cancer
biomarker
cancer stem cell
NANOG
chemotherapy
platinum
Online Access:https://www.dovepress.com/nanog-as-an-adverse-predictive-marker-in-advanced-non-small-cell-lung--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/nanog-as-an-adverse-predictive-marker-in-advanced-non-small-cell-lung--peer-reviewed-article-OTT

Similar Items